🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

233,04 USD

Máx. histórico

242,48

5 días

Caída desde máximo

-3,89%

Rango 52 semanas

80,91 – 248,75

Variación hoy

-2,33%

Cierre anterior

238,61

Rango de hoy

230,00 – 240,76

Volumen hoy

10.706.919

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,27%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 17 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/06/2023 69,81 71,86 69,30 70,81 +0,67% 3,67% 536.800
28/06/2023 69,49 70,58 69,07 70,34 +1,18% 2,17% 541.100
27/06/2023 68,86 69,82 68,63 69,52 +1,06% 1,73% 393.500
26/06/2023 68,25 68,90 67,44 68,79 +1,96% 2,14% 440.900
23/06/2023 66,34 68,34 66,06 67,47 +0,51% 3,44% 717.400
22/06/2023 64,84 67,93 64,41 67,13 +3,42% 5,43% 341.100
21/06/2023 66,37 66,52 64,78 64,91 -2,52% 2,62% 409.500
20/06/2023 67,33 67,76 66,55 66,59 -1,67% 1,80% 449.800
16/06/2023 69,31 69,31 66,81 67,72 +0,34% 3,61% 1.113.600
15/06/2023 66,94 68,44 66,44 67,49 +0,94% 2,98% 608.500
14/06/2023 67,96 68,29 65,69 66,86 +0,45% 3,83% 654.400
13/06/2023 66,75 67,19 65,93 66,56 -0,55% 1,88% 417.600
12/06/2023 67,50 68,33 66,70 66,93 -0,62% 2,41% 323.100
09/06/2023 68,07 68,90 66,25 67,35 -1,33% 3,89% 740.700
08/06/2023 66,12 70,05 65,52 68,26 +2,57% 6,85% 809.600
07/06/2023 67,05 68,67 65,57 66,55 +2,67% 4,62% 911.000
06/06/2023 62,35 65,21 61,81 64,82 +3,53% 5,46% 759.400
05/06/2023 62,17 63,17 61,69 62,61 +0,79% 2,37% 572.800
02/06/2023 59,64 63,61 58,88 62,12 +5,59% 7,93% 1.627.700
01/06/2023 56,96 58,83 56,53 58,83 +3,17% 4,04% 291.400
31/05/2023 55,95 57,27 55,35 57,02 +2,50% 3,43% 629.600
30/05/2023 54,90 55,99 54,38 55,63 +1,42% 2,92% 298.900
26/05/2023 55,31 55,84 54,76 54,85 -0,69% 1,95% 248.700
25/05/2023 56,43 56,43 54,84 55,23 -2,52% 2,82% 414.700
24/05/2023 57,89 57,98 56,61 56,66 -2,75% 2,37% 309.900
23/05/2023 58,88 60,09 57,64 58,26 -1,75% 4,16% 467.800
22/05/2023 58,66 59,76 58,66 59,30 +1,04% 1,88% 384.100
19/05/2023 60,46 61,01 58,57 58,69 -2,13% 4,03% 443.700
18/05/2023 59,15 61,00 58,11 59,97 +0,50% 4,88% 576.300
17/05/2023 60,35 60,54 59,05 59,67 -0,38% 2,47% 268.300